ZA200702075B - Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor - Google Patents

Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor

Info

Publication number
ZA200702075B
ZA200702075B ZA200702075A ZA200702075A ZA200702075B ZA 200702075 B ZA200702075 B ZA 200702075B ZA 200702075 A ZA200702075 A ZA 200702075A ZA 200702075 A ZA200702075 A ZA 200702075A ZA 200702075 B ZA200702075 B ZA 200702075B
Authority
ZA
South Africa
Prior art keywords
adp
ribose
poly
therapeutic combinations
polymerases
Prior art date
Application number
ZA200702075A
Inventor
Steinfeldt Heidi Marie
Calvert Alan Hilary
Dewji Mohamed Raza
Jones Christopher
Karen J Klamerus
Plummer Elizabeth Ruth
Ian J Stratford
Williams Kaye Janine
Boritzki Theodore James
Curtin Nicola Jane
Hostomsky Zdenek
Kaufman Rhonda
Newell David Richard
Reich Steven David
Thomas Huw David
Original Assignee
Pfizer
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Cancer Rec Tech Ltd filed Critical Pfizer
Publication of ZA200702075B publication Critical patent/ZA200702075B/en

Links

ZA200702075A 2004-09-22 2007-03-09 Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor ZA200702075B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61245804P 2004-09-22 2004-09-22

Publications (1)

Publication Number Publication Date
ZA200702075B true ZA200702075B (en) 2009-04-29

Family

ID=40463720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702075A ZA200702075B (en) 2004-09-22 2007-03-09 Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor

Country Status (2)

Country Link
CN (1) CN101384264B (en)
ZA (1) ZA200702075B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3150610T3 (en) * 2010-02-12 2019-11-04 Pfizer SALTS AND POLYMORPHS OF 8-FLUORO-2- {4 - [(METHYLAMINO} METHYL] PHENYL} -1,3,4,5-TETRAHYDRO-6H-AZEPINO [5,4,3-CD] INDOL-6-ON
US20210369681A1 (en) * 2018-10-22 2021-12-02 Yale University Identification of PPM1D mutations as a novel biomarker for NAMPTi sensitivity

Also Published As

Publication number Publication date
CN101384264B (en) 2012-03-14
CN101384264A (en) 2009-03-11

Similar Documents

Publication Publication Date Title
IL181681A0 (en) Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
ZA200604774B (en) Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly (ADP-ribose) polymerase inhibitors
EP1729761A4 (en) Cadasil treatment with cholinesterase inhibitors
IL219642A0 (en) Catheter
GB2428141B (en) Shelving
SG156643A1 (en) One time password
EP1787673A4 (en) Catheter
EP1789709A4 (en) Stopcock
IL177155A0 (en) Therapeutic combinations
SI1811990T1 (en) Anti-demodicosis agent
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
GB0424339D0 (en) Combination therapy
ZA200702075B (en) Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor
GB0426141D0 (en) Treatment
GB0410817D0 (en) Vascular damaging therapy
GB0421136D0 (en) Sequences
GB0425059D0 (en) Restrictor
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0400310D0 (en) Anti-incrustation agent
GB0408959D0 (en) Therapeutic agent
GB0406450D0 (en) Combination therapy
GB0407755D0 (en) Combination therapy
GB0406546D0 (en) Combination therapy